AMARIN CORP PLC\UK Preferred Stock, Value, Issued
AMARIN CORP PLC\UK (AMRN) had Preferred Stock, Value, Issued of $5.43 million as of 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2021-02-25
- 2020-09-30: Preferred Stock, Value, Issued $5.43M.
- 2020-06-30: Preferred Stock, Value, Issued $7.17M.
- 2020-03-31: Preferred Stock, Value, Issued $21.85M.
- 2019-12-31: Preferred Stock, Value, Issued $21.85M.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2020-09-30 | $5.43M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $7.17M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $21.85M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $21.85M 10-K · filed 2021-02-25 |
| 2019-09-30 | $21.85M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $21.85M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $21.85M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $21.85M 10-K · filed 2020-02-25 |
| 2018-09-30 | $21.85M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $24.36M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $24.36M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $24.36M 10-K · filed 2019-02-27 |
| 2017-09-30 | $24.36M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $24.36M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $24.36M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $24.36M 10-K · filed 2018-02-27 |
| 2016-09-30 | $24.36M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $24.36M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $24.36M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $24.36M 10-K · filed 2017-03-01 |
| 2015-09-30 | $24.36M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $21.38M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $26.18M 10-Q · filed 2015-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |